Lux Biosciences
A biotechnology company that develops medicines to address ophthalmic disease
1
Funding Rounds
$50.0m
Money raised
Overview
A biotechnology company that develops medicines to address ophthalmic disease
- Website:
- Business model: B2B
Funding series
Funding Series Analysis
The company Lux Biosciences has raised a total of $50m in funding over 1 rounds.
Key Insights:
- Lux Biosciences Series B round: $50m
Lux Biosciences Series B round
$50m
Industries
Lux Biosciences is active in the following industries: